Market Place
Sourcing Support
BridgeBio presents detailed +ve results from Ph3 ATTRibute-CM study acoramidis
27 Aug 2023 //
GLOBENEWSWIRE
BridgeBio heart disease med vindicated with phase 3 victory
17 Jul 2023 //
FIERCE BIOTECH
BridgeBio shares crash as their lead PhIII drug fails
28 Dec 2021 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.